Clinical Trials

Inclusion Criteria:

• Age 18 years or older at the time of signing informed consent.
• Undergoing transplant evaluation or currently on the heart transplant waiting list and expected to receive a heart transplant.
• Able to read, understand and provide written informed consent. If the patient is unable to sign the informed consent, a legally authorized representative (LAR) can consent on behalf of the patient.
• Able and willing to comply with the study visit schedule, study procedures and study requirements.

Exclusion Criteria:

• Concurrent multiple solid organ or tissue transplants.
• Prior history of any organ or cellular transplantation.
• Planned use of other commercially available or investigational cfDNA or gene expression profile assays for rejection surveillance.
• Pregnant.
• Hemodynamically unstable or other serious medical condition that may adversely affect the subject’s ability to participate in the study.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/13/2024. Questions regarding updates should be directed to the study team contact.